搜尋結果
How digital health companies are capitalizing on the GLP-1 boom
CNBC· 11 小時前Novo Nordisk's blockbuster weight loss drug, which contains the second generation GLP-1 ...
Rafael Nadal Is Not 100% Sure This Will Be His Final French Open
Forbes· 19 小時前Rafael Nadal has a message for everything saying and writing that this will be his final French ...
Ozempic Drug Semaglutide Could Protect Kidneys, Study Finds
Forbes· 19 小時前Novo Nordisk’s weight loss injection semaglutide — the ingredient inside its wildly popular ...
‘Underwhelming’ stimulus won’t rescue China’s grounded property market: analysts
South China Morning Post· 22 小時前“This is a buyer-led market, where I must offer more benefits to lure buyers,” Xiong lamented. In fact, he worries that ...
FDA panel votes against Novo Nordisk's weekly insulin in type 1 diabetes patients
CNBC· 23 小時前Novo is aiming to be the first to hit the market with a weekly insulin product, offering an ...
Pemex production hurt by late payments to suppliers, sources say
Reuters· 1 日前Mexican state energy company Pemex had its crude oil production hit because it keeps ...
Automotive industry leader to grow business in China by 50%
China Daily· 1 日前Aptiv, a leader in the automotive parts industry, aims to grow its business in China by 50 percent over the next five years ...
Big tech companies are plowing money into AI startups, which could help them dodge antitrust ...
TechCrunch· 1 日前DeepL, an AI language translation startup, raised $300 million on a $2 billion valuation; Scale ...
Novo Nordisk's Ozempic slows diabetic kidney disease progression in trial
Reuters· 2 日前, opens new tab Ozempic slowed the worsening of kidney dysfunction in patients with type 2 ...
Clay court king 'impossible' to dethrone in Paris
China Daily· 2 日前When a weary David Ferrer managed to win just five games in his French Open semifinal loss to Rafael Nadal in 2012, he was ...